本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cellectar Biosciences Inc.

2.35
+0.03001.29%
盤後2.350.00000.00%19:30 EDT
成交量:7.30萬
成交額:17.18萬
市值:2,221.24萬
市盈率:-1.06
高:2.39
開:2.32
低:2.32
收:2.32
52周最高:6.52
52周最低:2.20
股本:945.21萬
流通股本:900.82萬
量比:1.82
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-2.2100
每股收益(LYR):-8.3544
淨資產收益率:-119.57%
總資產收益率:-58.44%
市淨率:0.74
市盈率(LYR):-0.28

資料載入中...

2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/11

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

重要事件披露

Form 8-K - Current report